Masaya Miyamoto - Concepedia

Author

Masaya Miyamoto

The University of Tokyo

Also Known As

Masaya Miyamoto, Miyamoto, Masaya

Publications

339

Citations

H-Index

Concepts

All Affiliations

The University of Tokyo Daiichi-Sankyo (Japan)

About

Masaya Miyamoto is an author at The University of Tokyo specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	185
2	Cell Biology	6	6	185
3	Cancer Cell Biology	2	2	88
4	Pathology	1	1	15
5	Pharmacology	1	1	18

Masaya Miyamoto

Publications

330

Citations

H-Index

Page 1

	Year	Citations
The new-generation selective ROS1/NTRK inhibitor DS-6051b overcomes crizotinib resistant ROS1-G2032R mutation in preclinical models Ryohei Katayama, Bo Gong, Noriko Togashi, Nature Communications	2019	135
REG4 is a transcriptional target of GATA6 and is essential for colorectal tumorigenesis Yoshihiro Kawasaki, Kosuke Matsumura, Masaya Miyamoto, Scientific Reports Transcriptional RegulationDevelopmental BiologyGata6 ExpressionMedicineColon Cancer Cells	2015	51
The miR-1-NOTCH3-Asef Pathway Is Important for Colorectal Tumor Cell Migration Shiori Furukawa, Yoshihiro Kawasaki, Masaya Miyamoto, PLoS ONE Cancer ResearchSignaling PathwayCell SignalingMedicineAsef Promoter	2013	48
The novel lnc <scp>RNA</scp> <i> <scp>CALIC</scp> </i> upregulates <scp>AXL</scp> to promote colon cancer metastasis Yoshihiro Kawasaki, Masaya Miyamoto, Takeaki Oda, EMBO Reports Cancer ResearchMedicineCancer Cell BiologyColon Cancer MetastasisTumor Suppressor	2019	37
Highly potent, orally active novel small-molecule HPK1 inhibitor DS21150768 induces anti-tumor responses in multiple syngeneic tumor mouse models Genzui Setsu, Megumi Goto, Kentaro Ito, European Journal of Pharmacology MedicineAnti-tumor ResponsesPharmacologyHighly PotentImmune Checkpoint Inhibitor	2023	18
Cuf2 boosts the transcription of APC/C activator Fzr1 to terminate the meiotic division cycle Yuki Aoi, Kunio Arai, Masaya Miyamoto, EMBO Reports ChromatinTranscriptional RegulationCell RegulationCell DivisionGenetics	2013	16
Novel protein kinase cAMP-Activated Catalytic Subunit Alpha (PRKACA) inhibitor shows anti-tumor activity in a fibrolamellar hepatocellular carcinoma model Akiko Toyota, Megumi Goto, Masaya Miyamoto, Biochemical and Biophysical Research Communications Cancer ResearchMedicinePathologyProtein PhosphorylationTumor Suppressor	2022	15
Sp5 negatively regulates the proliferation of HCT116 cells by upregulating the transcription of p27 Masaya Miyamoto, Tomoatsu Hayashi, Yoshihiro Kawasaki, Oncology Letters	2018	10

Page 1